RE: Just been tipped30 Mar 2017 10:22
FYI here's the text of yesterday's tip by Simon Thompson:
"Watkin Jones buying opportunity
CareTech is not the only company on my active buy list that has conducted a major fundraising. The same is true of Watkin Jones(WJG:145.5p), a construction company specialising in purpose-built student accommodation (PBSA).
It's a company I know well, having advised buying the shares around the 103p mark at the time it joined Aim last year ('A profitable education', 3 April 2016). I last rated the shares a buy at 134.5p a couple of months ago ('In the ascent', 23 January 2017) and my upgraded target of 155p was surpassed earlier this month when the price hit an all-time high of 162p.
However, last week's placing of 49.25m shares at 140p by a family trust in which chief executive Mark Watkin Jones is a beneficiary, and the sale of 1m shares by finance director Philip Byrom, has led to a sharp pullback in the share price. It looks overdone, though, as Mr Watkin Jones still has an interest in over 29 per cent of the share capital, and Mr Byrom only sold less than a quarter of his holding, while liquidity in the shares has improved as new investors have come on board, including fund manager Woodford Investment Management, which snapped up 10.2 per cent of the shares in issue.
Indeed, I feel that when the dust settles investors will focus once again on the sound fundamentals of the business, which has driven the share price higher since listing. Namely, the company has 21 developments with 6,800 beds slated for delivery during 2017 and 2018 and the pipeline beyond 2018 is robust - future earnings have been de-risked through forward sales of schemes to institutional investors, including all 10 projects due to be delivered this year and the profits and hefty cash generation realised from these schemes supports a highly progressive dividend policy.
In my view, it now looks a rock solid bet that Watkin Jones will grow EPS by around 10 per cent to 13.7p in the 12 months to 30 September 2017. So, with profits rolling in, and net funds of £32.2m on the company's balance sheet worth 12.6p a share, a 50 per cent-plus hike in the dividend per share to north of 6p looks on the cards. This implies the shares are trading on around 10.5 times likely earnings and offer a prospective dividend yield in excess of 4 per cent. In my book, that represents value and offers ample upside to my new price target of 165p to 170p, so I continue to rate the shares a buy."